These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 12911582

  • 21. Response to desmopressin of factors XI, X and V in patients with factor VIII deficiency and von Willebrand disease.
    White B, Lawler P, Riddell A, Nitu-Whalley IC, Hermans C, Lee CA, Brown SA.
    Br J Haematol; 2004 Jul; 126(1):100-4. PubMed ID: 15198739
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ, van Vliet HH.
    Acta Haematol; 2009 Jul; 121(2-3):154-66. PubMed ID: 19506362
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease.
    Gill JC, Ottum M, Schwartz B.
    J Pediatr; 2002 May; 140(5):595-9. PubMed ID: 12032528
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series.
    Casonato A, Gallinaro L, Cattini MG, Sartorello F, Pontara E, Padrini R, Bertomoro A, Daidone V, Pagnan A.
    Transl Res; 2010 Apr; 155(4):200-8. PubMed ID: 20303469
    [Abstract] [Full Text] [Related]

  • 29. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
    Lethagen S, Harris AS, Nilsson IM.
    Blut; 1990 Mar; 60(3):187-91. PubMed ID: 2107887
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content.
    Casonato A, Sartori MT, Pontara E, Zucchetto A, Dannhäuser D, Patrassi G, Girolami A.
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):149-53. PubMed ID: 1606286
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Von Willebrand disease: characteristics and response to desmopressin. Study of 103 cases].
    César JM, Avello AG, Vecino A, Cerveró C, Laraña JG, Fuertes IF, Villarrubia J, López J, de Oteyza JP, Velasco JL, Cantalapiedra A, Herrera P, Herrero S, Navarro JL.
    Med Clin (Barc); 1998 Nov 14; 111(16):601-3. PubMed ID: 9881332
    [Abstract] [Full Text] [Related]

  • 39. Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease.
    Castaman G, Lattuada A, Mannucci PM, Rodeghiero F.
    Br J Haematol; 1995 Jan 14; 89(1):147-51. PubMed ID: 7833254
    [Abstract] [Full Text] [Related]

  • 40. Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease.
    Bykowska K, Letowska M, Sabliński J, Binder BR, Kopeć M, Lopaciuk S.
    Acta Haematol Pol; 1994 Jan 14; 25(3):261-8. PubMed ID: 7992599
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.